TIMOTHY J. ACKERMAN Insider Trading
Get free email notifications about insider trading for TIMOTHY J. ACKERMAN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of TIMOTHY J. ACKERMAN. TIMOTHY J. ACKERMAN is a SVP, Commercial Operations in Horizon Pharma plc ($HZNP).
Address: C/O HORIZON PHARMA PLC CONNAUGHT HOUSE, 1ST FL, 1 BURLINGTON RD DUBLIN 4Ireland
Companies in which TIMOTHY J. ACKERMAN is an Insider
Horizon Therapeutics Public Ltd Co
Trading Symbol: HZNPIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of TIMOTHY J. ACKERMAN: SVP, Commercial Operations
Holdings: 39,314 shares
Current Value: $662,834
Latest Transaction: Jan 11 2017
$HZNP Market Capitalization: $2.68B
$HZNP Previous Close: $16.86
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of TIMOTHY J. ACKERMAN
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 11 2017 | HZNP | Horizon Pharma plc | ACKERMAN TIMOTHY J. | SVP, Commercial Ope ... | Option Exercise | M | 2.40 | 1,815 | 4,356 | 0 | |
Jan 11 2017 | HZNP | Horizon Pharma plc | ACKERMAN TIMOTHY J. | SVP, Commercial Ope ... | Option Exercise | M | 7.48 | 7,860 | 58,793 | 0 | |
Jan 11 2017 | HZNP | Horizon Pharma plc | ACKERMAN TIMOTHY J. | SVP, Commercial Ope ... | Buy | M | 2.40 | 1,815 | 4,356 | 41,129 | 39.3 K to 41.1 K (+4.62 %) |
Jan 11 2017 | HZNP | Horizon Pharma plc | ACKERMAN TIMOTHY J. | SVP, Commercial Ope ... | Buy | M | 7.48 | 7,860 | 58,793 | 39,314 | 31.5 K to 39.3 K (+24.99 %) |
Dec 19 2016 | HZNP | Horizon Pharma plc | ACKERMAN TIMOTHY J. | SVP, Commercial Ope ... | Option Exercise | A | 0.00 | 10,000 | 0 | 10,000 | |
Nov 08 2016 | HZNP | Horizon Pharma plc | ACKERMAN TIMOTHY J. | SVP, Commercial Ope ... | Option Exercise | M | 0.00 | 2,500 | 0 | 5,000 | |
Nov 08 2016 | HZNP | Horizon Pharma plc | ACKERMAN TIMOTHY J. | SVP, Commercial Ope ... | Payment of Exercise | F | 15.05 | 778 | 11,709 | 31,454 | 32.2 K to 31.5 K (-2.41 %) |